Research on the COVID-19 virus is uncovering the virus may, in some cases, be attacking endothelial cells and potentially causing systemic inflammation. This paper titled "Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke" showcases research that utilized our human primary brain microvascular endothelial cells (ACBRI 376).
Cell Systems offers a wide variety of human primary endothelial cells that are isolated without the use of antibodies. Our cells are more biologically relevant and offer outstanding consistency and quality for your research programs.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256621/pdf/main.pdf